Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$9.10 +0.79 (+9.51%)
At close: Sep 30, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Times Interest Earned (2023 - 2024)

Updated

Eupraxia Pharmaceuticals' (EPRX) Times Interest Earned stood at -54968.43 in the quarter ended Dec 31, 2024.

Analysis

Eupraxia Pharmaceuticals (EPRX) Times Interest Earned (2023 - 2024) Analysis & Trends

For the year ended Dec 31, 2024, Eupraxia Pharmaceuticals' Times Interest Earned came in at -43.65.

  • Across earlier years, Times Interest Earned came in at -25.72 in the year ended Dec 31, 2023 and -20.32 in the year ended Dec 31, 2022.
  • Per Business Quant, the preceding three quarters came in at -13285.52 (quarter ended Sep 30, 2024), -22.53 (quarter ended Jun 30, 2024) and -20.16 (quarter ended Mar 31, 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.41
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 10.28
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 7.27
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 5.22
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -42.08
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Eupraxia Pharmaceuticals 363.60 Mn 362.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -54,968.43
Sep 30, 2024 -13,285.52
Jun 30, 2024 -22.53
Mar 31, 2024 -20.16
Jun 30, 2023 -32.50
Mar 31, 2023 -14.57
API Access

Eupraxia Pharmaceuticals Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=EPRX&period=max&api_key=YOUR_API_KEY